Adalimumab Injection

Generic name: Pronounced as (a dal aye' mu mab)
Brand names
  • Humira® Injection
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 04/15/2021

Using adalimumab injection may decrease your ability to fight infection and increase the chance that you will develop a serious infection, including severe fungal, bacterial, and viral infection that may spread through the body. These infections may need to be treated in a hospital and may cause death. Tell your doctor if you often get any type of infection or if you have or think you may have any type of infection now. This includes minor infections (such as open cuts or sores), infections that come and go (such as cold sores) or chronic infections that do not go away. Also tell your doctor if you have or have ever had any condition that affects your immune system or if you live or have ever lived in areas such as the Ohio or Mississippi river valleys where severe fungal infections are more common. Ask your doctor if you don't know if these infections are more common in your area. Tell your doctor if you are taking medications that decrease the activity of the immune system such as the following: abatacept (Orencia), anakinra (Kineret), certolizumab (Cimzia), etanercept (Enbrel), golimumab (Simponi), infliximab (Remicade), methotrexate (Otrexup, Rasuvo, Trexall), rituximab (Rituxan), or steroids such as dexamethasone, methylprednisolone (Medrol), prednisone (Rayos), or prednisolone (Prelone).

Your doctor will monitor you for signs of infection during and after your treatment. If you have any of the following symptoms before you begin your treatment or if you experience any of the following symptoms during or shortly after your treatment, call your doctor immediately: weakness; sweating; sore throat; cough; coughing up bloody mucus; fever; weight loss; extreme tiredness; diarrhea; stomach pain; warm, red, or painful skin; painful, difficult, or frequent urination; or other signs of infection.

You may already be infected with tuberculosis (TB; a serious lung infection) or hepatitis B (a virus that affects the liver) but not have any symptoms of the disease. In this case, adalimumab injection may increase the risk that your infection will become more serious and you will develop symptoms. Your doctor will perform a skin test to see if you have an inactive TB infection and may order a blood test to see if you have an inactive hepatitis B infection. If necessary, your doctor may give you medication to treat this infection before you begin your treatment with adalimumab. Tell your doctor if you have or have ever had TB, if you have lived in or visited a country where TB is common, or if you have been around someone who has or has ever had TB. If you have any of the following symptoms of TB, or if you develop any of these symptoms during your treatment, call your doctor immediately: cough, weight loss, loss of muscle tone,fever, or night sweats. Also call your doctor immediately if you have any of these symptoms of hepatitis B or if you develop any of these symptoms during or after your treatment: excessive tiredness, yellowing of the skin or eyes, loss of appetite, nausea or vomiting, muscle aches, dark urine, clay-colored bowel movements, fever, chills, stomach pain, or rash.

Some children, teenagers, and young adults who received adalimumab injection or similar medications developed severe or life-threatening cancers including lymphoma (cancer that begins in the cells that fight infection). Some teenage and young adult males who took adalimumab or similar medications developed hepatosplenic T-cell lymphoma (HSTCL), a very serious form of cancer that often causes death within a short period of time. Most of the people who developed HSTCL were being treated for Crohn's disease (a condition in which the body attacks the lining of the digestive tract, causing pain, diarrhea, weight loss, and fever) or ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum) with adalimumab or a similar medication along with another medication called azathioprine (Imuran) or 6-mercaptopurine (Purinethol). Tell your child's doctor if your child has ever had any type of cancer. If your child develops any of these symptoms during his or her treatment, call his or her doctor immediately: stomach pain; fever; unexplained weight loss; swollen glands in the neck, underarms, or groin; or easy bruising or bleeding. Talk to your child's doctor about the risks of giving adalimumab injection to your child.

Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with adalimumab injection and each time you receive the medication. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) or the manufacturer's website to obtain the Medication Guide.

Talk to your doctor about the risks of using adalimumab injection.

Adalimumab injection is used alone or with other medications to relieve the symptoms of certain autoimmune disorders (conditions in which the immune system attacks healthy parts of the body and causes pain, swelling, and damage) including the following:

  • rheumatoid arthritis (a condition in which the body attacks its own joints, causing pain, swelling, and loss of function) in adults,

  • juvenile idiopathic arthritis (JIA; a condition that affects children in which the body attacks its own joints, causing pain, swelling, loss of function, and delays in growth and development) in children 2 years of age and older,

  • Crohn's disease (a condition in which the body attacks the lining of the digestive tract, causing pain, diarrhea, weight loss, and fever) that has not improved when treated with other medications in adults and children 6 years of age and older,

  • ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum) when other medications and treatments did not help or could not be tolerated in adults and children 5 years of age and older,

  • ankylosing spondylitis (a condition in which the body attacks the joints of the spine and other areas causing pain and joint damage) in adults,

  • psoriatic arthritis (a condition that causes joint pain and swelling and scales on the skin) in adults,

  • hidradenitis suppurativa (a skin disease that causes pimple-like bumps in the armpits, groin, and anal area) in adults and children 12 years of age and older,

  • uveitis (swelling and inflammation of different areas of the eye) in adults and children 2 years of age and older,

  • chronic plaque psoriasis (a skin disease in which red, scaly patches form on some areas of the body) in adults.

Adalimumab injection is in a class of medications called tumor necrosis factor (TNF) inhibitors. It works by blocking the action of TNF, a substance in the body that causes inflammation.

Adalimumab injection comes as a solution (liquid) to inject subcutaneously (under the skin). Your doctor will tell you how often to use adalimumab based on your condition and age. To help you remember to inject adalimumab injection, mark the days you are scheduled to inject it on your calendar. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Use adalimumab injection exactly as directed. Do not use more or less of it or use it more often than prescribed by your doctor.

You will receive your first dose of adalimumab injection in your doctor's office. After that, you can inject adalimumab injection yourself or have a friend or relative perform the injections. Before you use adalimumab injection yourself the first time, read the written instructions that come with it. Ask your doctor or pharmacist to show you or the person who will be injecting the medication how to inject it.

Adalimumab injection comes in prefilled syringes and dosing pens. Use each syringe or pen only once and inject all the solution in the syringe or pen. Even if there is still some solution left in the syringe or pen after you inject, do not inject again. Dispose of used syringes and pens in a puncture-resistant container. Talk to your doctor or pharmacist about how to dispose of the puncture-resistant container.

If you are using a prefilled syringe or a dosing pen that has been refrigerated, place the syringe or pen on a flat surface without removing the needle cap and allow it warm to room temperature for 15 to 30 minutes before you are ready to inject the medication. Do not try to warm the medication by heating it in a microwave, placing it in hot water, or through any other method.

Be careful not to drop or crush the prefilled syringes or dosing pens. These devices are made of glass or contain glass and may break if they are dropped.

You can inject adalimumab injection anywhere on the front of your thighs or stomach except your navel and the area 2 inches (5 centimeters) around it. To reduce the chances of soreness or redness, use a different site for each injection. Give each injection at least 1 inch (2.5 centimeters) away from a spot that you have already used. Keep a list of the places where you have given injections so that you will not inject in these places again. Do not inject into an area where the skin is tender, bruised, red, or hard or where you have scars or stretch marks.

Always look at adalimumab injection solution before injecting it. Check that the expiration date has not passed, that the syringe or dosing pen contains the correct amount of liquid, and that the liquid is clear and colorless. Do not use a syringe or dosing pen if it is expired, if it does not contain the correct amount of liquid, or if the liquid is cloudy or contains flakes.

Adalimumab injection may help control your condition but will not cure it. Continue to use adalimumab injection even if you feel well. Do not stop using adalimumab injection without talking to your doctor.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before using adalimumab injection,

  • tell your doctor and pharmacist if you are allergic to adalimumab injection, any other medications, or any of the ingredients in adalimumab injection. Ask your pharmacist or check the Medication Guide for a list of the ingredients. If you will be using the prefilled syringe, also tell your doctor if you or the person who will be helping you inject adalimumab injection are allergic to latex or rubber.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention the medications listed in the IMPORTANT WARNING section and any of the following: cyclosporine (Gengraf, Neoral, Sandimmune), theophylline (Elixophyllin,Theo 24, Theochron), or warfarin (Coumadin, Jantoven). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • in addition to the conditions mentioned in the IMPORTANT WARNING section, tell your doctor if you have or have ever had numbness or tingling in any part of your body, any disease that affects your nervous system, such as multiple sclerosis (a disease in which the nerves do not function properly causing weakness, numbness, loss of muscle coordination and problems with vision, speech, and bladder control), Guillain-Barré syndrome (weakness, tingling, and possible paralysis due to sudden nerve damage), or optic neuritis (inflammation of the nerve that sends messages from the eye to the brain); any type of cancer, diabetes, heart failure, or heart disease. If you have psoriasis, tell your doctor if you have been treated with light therapy.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding If you become pregnant while using adalimumab injection, call your doctor.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are using adalimumab injection.

  • do not have any vaccinations without talking to your doctor. If your child will be receiving adalimumab injection, be sure that your child has received all the shots that are required for children of his or her age before he or she begins treatment with adalimumab injection.

Unless your doctor tells you otherwise, continue your normal diet.

Inject the missed dose as soon as you remember it. Then inject the next dose on your regularly scheduled day. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not use a double dose to make up for a missed one.

  • Adalimumab injection may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • redness, itching, bruising, pain, or swelling in the place you injected adalimumab injection

    • nausea

    • headache

    • back pain

  • Some side effects can be serious. If you experience any of the following symptoms or those listed in the IMPORTANT WARNING section, call your doctor immediately or get emergency care:

    • numbness or tingling

    • problems with vision

    • weakness in legs

    • chest pain

    • shortness of breath

    • rash, especially a rash on the cheeks or arms that is sensitive to sunlight

    • new joint pain

    • hives

    • itching

    • swelling of the face, feet, ankles, or lower legs

    • difficulty breathing or swallowing

    • fever, sore throat, chills, and other signs of infection

    • unusual bruising or bleeding

    • pale skin

    • dizziness

    • red, scaly patches or pus-filled bumps on the skin

  • Adults who receive adalimumab injection may be more likely to develop skin cancer, lymphoma, and other types of cancer than people who do not receive adalimumab injection. Talk to your doctor about the risks of receiving this medication.

  • Adalimumab injection may cause other side effects. Call your doctor if you have any unusual problems while using this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it in the refrigerator and protect it from light. Adalimumab injection may also be stored at room temperature (up to 77°F [25°C]) for up to 14 days and protected from light. If adalimumab injection is stored at room temperature for more than 14 days and it is not used, it must be disposed. Do not freeze it. Dispose of any medication that has been frozen.

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests before, during, and after your treatment to check your body's response to adalimumab.

Do not let anyone else use your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Penbutolol Penbutolol The metabolism of Acebutolol can be increased when combined with Adalimumab.
Triamcinolone Triamcinolone The metabolism of Triamcinolone can be increased when combined with Adalimumab.
Zolmitriptan Zolmitriptan The metabolism of Zolmitriptan can be increased when combined with Adalimumab.
Zidovudine Injection Zidovudine Injection The metabolism of Zidovudine can be increased when combined with Adalimumab.
Linezolid Linezolid The risk or severity of adverse effects can be increased when Adalimumab is combined with Linezolid.
Trimipramine Trimipramine The metabolism of Trimipramine can be increased when combined with Adalimumab.
Tenofovir Tenofovir The metabolism of Tenofovir can be increased when combined with Adalimumab.
Tegaserod Tegaserod The metabolism of Tegaserod can be increased when combined with Adalimumab.
Apomorphine Injection Apomorphine Injection The metabolism of Apomorphine can be increased when combined with Adalimumab.
Infliximab Injection Infliximab Injection Adalimumab may increase the immunosuppressive activities of Infliximab.
Voriconazole Voriconazole The metabolism of Voriconazole can be increased when combined with Adalimumab.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Adalimumab.
Darifenacin Darifenacin The metabolism of Darifenacin can be increased when combined with Adalimumab.
Tipranavir Tipranavir The metabolism of Tipranavir can be increased when combined with Adalimumab.
Rasagiline Rasagiline The metabolism of Rasagiline can be increased when combined with Adalimumab.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Adalimumab.
Rituximab Injection Rituximab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Rituximab.
Vorinostat Vorinostat The risk or severity of adverse effects can be increased when Adalimumab is combined with Vorinostat.
Dronabinol Dronabinol The metabolism of Dronabinol can be increased when combined with Adalimumab.
Azacitidine Injection Azacitidine Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Azacitidine.
Budesonide Budesonide The risk or severity of adverse effects can be increased when Adalimumab is combined with Budesonide.
Decitabine Injection Decitabine Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Decitabine.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Arsenic trioxide.
Tretinoin Tretinoin The metabolism of Tretinoin can be increased when combined with Adalimumab.
Bendamustine Injection Bendamustine Injection The metabolism of Bendamustine can be increased when combined with Adalimumab.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Adalimumab is combined with Alemtuzumab.
Betaxolol Betaxolol The metabolism of Betaxolol can be increased when combined with Adalimumab.
Everolimus Everolimus The metabolism of Everolimus can be increased when combined with Adalimumab.
Fingolimod Fingolimod Adalimumab may increase the immunosuppressive activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Eribulin.
Acetaminophen Injection Acetaminophen Injection The metabolism of Acetaminophen can be increased when combined with Adalimumab.
Vilazodone Vilazodone The metabolism of Vilazodone can be increased when combined with Adalimumab.
Ipilimumab Injection Ipilimumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Ipilimumab.
Belimumab Injection Belimumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Belimumab.
Busulfan Injection Busulfan Injection The metabolism of Busulfan can be increased when combined with Adalimumab.
Roflumilast Roflumilast Adalimumab may increase the immunosuppressive activities of Roflumilast.
Linagliptin Linagliptin The metabolism of Linagliptin can be increased when combined with Adalimumab.
Rivaroxaban Rivaroxaban The metabolism of Rivaroxaban can be increased when combined with Adalimumab.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be increased when combined with Adalimumab.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be increased when combined with Adalimumab.
Vandetanib Vandetanib The metabolism of Vandetanib can be increased when combined with Adalimumab.
Vemurafenib Vemurafenib The metabolism of Vemurafenib can be increased when combined with Adalimumab.
Vismodegib Vismodegib The metabolism of Vismodegib can be increased when combined with Adalimumab.
Belatacept Injection Belatacept Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Belatacept.
Ivacaftor Ivacaftor The metabolism of Ivacaftor can be increased when combined with Adalimumab.
Basiliximab Injection Basiliximab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Basiliximab.
Axitinib Axitinib The metabolism of Axitinib can be increased when combined with Adalimumab.
Crizotinib Crizotinib The metabolism of Crizotinib can be increased when combined with Adalimumab.
Pertuzumab Injection Pertuzumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Pertuzumab.
Carfilzomib Injection Carfilzomib Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Carfilzomib.
Enzalutamide Enzalutamide The metabolism of Enzalutamide can be increased when combined with Adalimumab.
Mirabegron Mirabegron The metabolism of Mirabegron can be increased when combined with Adalimumab.
Regorafenib Regorafenib The metabolism of Regorafenib can be increased when combined with Adalimumab.
Bosutinib Bosutinib The metabolism of Bosutinib can be increased when combined with Adalimumab.
Teriflunomide Teriflunomide The risk or severity of adverse effects can be increased when Adalimumab is combined with Teriflunomide.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be increased when combined with Adalimumab.
Tofacitinib Tofacitinib The risk or severity of adverse effects can be increased when Adalimumab is combined with Tofacitinib.
Alogliptin Alogliptin The metabolism of Alogliptin can be increased when combined with Adalimumab.
Dimethyl Fumarate Dimethyl Fumarate The risk or severity of adverse effects can be increased when Adalimumab is combined with Dimethyl fumarate.
Ponatinib Ponatinib The metabolism of Ponatinib can be increased when combined with Adalimumab.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be increased when combined with Adalimumab.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be increased when combined with Adalimumab.
Apixaban Apixaban The metabolism of Apixaban can be increased when combined with Adalimumab.
Dabrafenib Dabrafenib The metabolism of Dabrafenib can be increased when combined with Adalimumab.
Ospemifene Ospemifene The metabolism of Ospemifene can be increased when combined with Adalimumab.
Levomilnacipran Levomilnacipran The metabolism of Levomilnacipran can be increased when combined with Adalimumab.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be increased when combined with Adalimumab.
Perampanel Perampanel The metabolism of Perampanel can be increased when combined with Adalimumab.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be increased when combined with Adalimumab.
Lomitapide Lomitapide The metabolism of Lomitapide can be increased when combined with Adalimumab.
Dapagliflozin Dapagliflozin The metabolism of Dapagliflozin can be increased when combined with Adalimumab.
Apremilast Apremilast The therapeutic efficacy of Apremilast can be decreased when used in combination with Adalimumab.
Ramucirumab Injection Ramucirumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Ramucirumab.
Ceritinib Ceritinib The metabolism of Ceritinib can be increased when combined with Adalimumab.
Siltuximab Injection Siltuximab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Siltuximab.
Vedolizumab Injection Vedolizumab Injection The risk or severity of infection can be increased when Adalimumab is combined with Vedolizumab.
Belinostat Injection Belinostat Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Belinostat.
Idelalisib Idelalisib The metabolism of Idelalisib can be increased when combined with Adalimumab.
Testosterone Injection Testosterone Injection The metabolism of Testosterone can be increased when combined with Adalimumab.
Vorapaxar Vorapaxar The metabolism of Vorapaxar can be increased when combined with Adalimumab.
Suvorexant Suvorexant The metabolism of Suvorexant can be increased when combined with Adalimumab.
Dulaglutide Injection Dulaglutide Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Dulaglutide.
Pembrolizumab Injection Pembrolizumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Pembrolizumab.
Nivolumab Injection Nivolumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Nivolumab.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Peginterferon beta-1a.
Olaparib Olaparib The metabolism of Olaparib can be increased when combined with Adalimumab.
Blinatumomab Injection Blinatumomab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Blinatumomab.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be increased when combined with Adalimumab.
Riociguat Riociguat The metabolism of Riociguat can be increased when combined with Adalimumab.
Pirfenidone Pirfenidone The metabolism of Pirfenidone can be increased when combined with Adalimumab.
Nintedanib Nintedanib The metabolism of Nintedanib can be increased when combined with Adalimumab.
Secukinumab Injection Secukinumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Secukinumab.
Palbociclib Palbociclib The metabolism of Palbociclib can be increased when combined with Adalimumab.
Panobinostat Panobinostat The metabolism of Panobinostat can be increased when combined with Adalimumab.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Dinutuximab.
Sonidegib Sonidegib The metabolism of Sonidegib can be increased when combined with Adalimumab.
Alirocumab Injection Alirocumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Alirocumab.
Evolocumab Injection Evolocumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Evolocumab.
Daclatasvir Daclatasvir The metabolism of Daclatasvir can be increased when combined with Adalimumab.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be increased when combined with Adalimumab.
Ziprasidone Injection Ziprasidone Injection The metabolism of Ziprasidone can be increased when combined with Adalimumab.
Cariprazine Cariprazine The metabolism of Cariprazine can be increased when combined with Adalimumab.
Cobimetinib Cobimetinib The metabolism of Cobimetinib can be increased when combined with Adalimumab.
Mepolizumab Injection Mepolizumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Mepolizumab.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be increased when combined with Adalimumab.
Elotuzumab Injection Elotuzumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Elotuzumab.
Daratumumab Injection Daratumumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Daratumumab.
Osimertinib Osimertinib The metabolism of Osimertinib can be increased when combined with Adalimumab.
Alectinib Alectinib The metabolism of Alectinib can be increased when combined with Adalimumab.
Ixazomib Ixazomib The metabolism of Ixazomib can be increased when combined with Adalimumab.
Necitumumab Injection Necitumumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Necitumumab.
Lesinurad Lesinurad The metabolism of Lesinurad can be increased when combined with Adalimumab.
Reslizumab Injection Reslizumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Reslizumab.
Ixekizumab Injection Ixekizumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Ixekizumab.
Brivaracetam Injection Brivaracetam Injection The metabolism of Brivaracetam can be increased when combined with Adalimumab.
Venetoclax Venetoclax The metabolism of Venetoclax can be increased when combined with Adalimumab.
Cobicistat Cobicistat The metabolism of Cobicistat can be increased when combined with Adalimumab.
Selexipag Selexipag The metabolism of Selexipag can be increased when combined with Adalimumab.
Atezolizumab Injection Atezolizumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Atezolizumab.
Olaratumab Injection Olaratumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Olaratumab.
Rucaparib Rucaparib The metabolism of Rucaparib can be increased when combined with Adalimumab.
Bezlotoxumab Injection Bezlotoxumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Bezlotoxumab.
Avelumab Injection Avelumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Avelumab.
Ribociclib Ribociclib The metabolism of Ribociclib can be increased when combined with Adalimumab.
Brodalumab Injection Brodalumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Brodalumab.
Brigatinib Brigatinib The metabolism of Brigatinib can be increased when combined with Adalimumab.
Dupilumab Injection Dupilumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Dupilumab.
Deutetrabenazine Deutetrabenazine The metabolism of Deutetrabenazine can be increased when combined with Adalimumab.
Valbenazine Valbenazine The metabolism of Valbenazine can be increased when combined with Adalimumab.
Ocrelizumab Injection Ocrelizumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Ocrelizumab.
Durvalumab Injection Durvalumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Durvalumab.
Sarilumab Injection Sarilumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Sarilumab.
Midostaurin Midostaurin The metabolism of Midostaurin can be increased when combined with Adalimumab.
Neratinib Neratinib The metabolism of Neratinib can be increased when combined with Adalimumab.
Guselkumab Injection Guselkumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Guselkumab.
Enasidenib Enasidenib The metabolism of Enasidenib can be increased when combined with Adalimumab.
Inotuzumab Ozogamicin Injection Inotuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Inotuzumab ozogamicin.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be increased when combined with Adalimumab.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be increased when combined with Adalimumab.
Abemaciclib Abemaciclib The metabolism of Abemaciclib can be increased when combined with Adalimumab.
Benralizumab Injection Benralizumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Benralizumab.
Acalabrutinib Acalabrutinib The metabolism of Acalabrutinib can be increased when combined with Adalimumab.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Gemtuzumab ozogamicin.
Letermovir Letermovir The metabolism of Letermovir can be increased when combined with Adalimumab.
Tetrabenazine Tetrabenazine The metabolism of Tetrabenazine can be increased when combined with Adalimumab.
Buprenorphine Injection Buprenorphine Injection The metabolism of Buprenorphine can be increased when combined with Adalimumab.
Apalutamide Apalutamide The metabolism of Apalutamide can be increased when combined with Adalimumab.
Ibalizumab-uiyk Injection Ibalizumab-uiyk Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Ibalizumab.
Tildrakizumab-asmn injection Tildrakizumab-asmn injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Tildrakizumab.
Erenumab-aooe Injection Erenumab-aooe Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Erenumab.
Baricitinib Baricitinib The metabolism of Baricitinib can be increased when combined with Adalimumab.
Burosumab-twza Injection Burosumab-twza Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Burosumab.
Eliglustat Eliglustat The metabolism of Eliglustat can be increased when combined with Adalimumab.
Encorafenib Encorafenib The metabolism of Encorafenib can be increased when combined with Adalimumab.
Binimetinib Binimetinib The metabolism of Binimetinib can be increased when combined with Adalimumab.
Ivosidenib Ivosidenib The metabolism of Ivosidenib can be increased when combined with Adalimumab.
Elagolix Elagolix The metabolism of Elagolix can be increased when combined with Adalimumab.
Doravirine Doravirine The metabolism of Doravirine can be increased when combined with Adalimumab.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be increased when combined with Adalimumab.
Cannabidiol Cannabidiol The metabolism of Cannabidiol can be increased when combined with Adalimumab.
Cemiplimab-rwlc Injection Cemiplimab-rwlc Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Cemiplimab.
Dacomitinib Dacomitinib The metabolism of Dacomitinib can be increased when combined with Adalimumab.
Duvelisib Duvelisib The metabolism of Duvelisib can be increased when combined with Adalimumab.
Galcanezumab-gnlm Injection Galcanezumab-gnlm Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Galcanezumab.
Mogamulizumab-kpkc Injection Mogamulizumab-kpkc Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Mogamulizumab.
Stiripentol Stiripentol The metabolism of Stiripentol can be increased when combined with Adalimumab.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be increased when combined with Adalimumab.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Drospirenone can be increased when combined with Adalimumab.
Theophylline Theophylline The serum concentration of Theophylline can be decreased when it is combined with Adalimumab.
Trazodone Trazodone The metabolism of Trazodone can be increased when combined with Adalimumab.
Thioguanine Thioguanine The risk or severity of adverse effects can be increased when Adalimumab is combined with Tioguanine.
Thioridazine Thioridazine The metabolism of Thioridazine can be increased when combined with Adalimumab.
Trifluoperazine Trifluoperazine The metabolism of Trifluoperazine can be increased when combined with Adalimumab.
Bleomycin Bleomycin The risk or severity of adverse effects can be increased when Adalimumab is combined with Bleomycin.
Sulfadiazine Sulfadiazine The metabolism of Sulfadiazine can be increased when combined with Adalimumab.
Benztropine Benztropine The metabolism of Benzatropine can be increased when combined with Adalimumab.
Azathioprine Azathioprine The metabolism of Azathioprine can be increased when combined with Adalimumab.
Carbamazepine Carbamazepine The metabolism of Carbamazepine can be increased when combined with Adalimumab.
Warfarin Warfarin The serum concentration of Warfarin can be decreased when it is combined with Adalimumab.
Triamterene Triamterene The metabolism of Triamterene can be increased when combined with Adalimumab.
Valproic Acid Valproic Acid The metabolism of Valproic acid can be increased when combined with Adalimumab.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be increased when combined with Adalimumab.
Tolbutamide Tolbutamide The metabolism of Tolbutamide can be increased when combined with Adalimumab.
Tolazamide Tolazamide The metabolism of Tolazamide can be increased when combined with Adalimumab.
Brompheniramine Brompheniramine The metabolism of Brompheniramine can be increased when combined with Adalimumab.
Carisoprodol Carisoprodol The metabolism of Carisoprodol can be increased when combined with Adalimumab.
Mercaptopurine Mercaptopurine The serum concentration of Mercaptopurine can be decreased when it is combined with Adalimumab.
Thiotepa Injection Thiotepa Injection The metabolism of Thiotepa can be increased when combined with Adalimumab.
Vincristine Injection Vincristine Injection The metabolism of Vincristine can be increased when combined with Adalimumab.
Vinblastine Vinblastine The metabolism of Vinblastine can be increased when combined with Adalimumab.
Thiothixene Thiothixene The metabolism of Thiothixene can be increased when combined with Adalimumab.
Aspirin Aspirin The metabolism of Acetylsalicylic acid can be increased when combined with Adalimumab.
Triazolam Triazolam The metabolism of Triazolam can be increased when combined with Adalimumab.
Trimethoprim Trimethoprim The metabolism of Trimethoprim can be increased when combined with Adalimumab.
Timolol Timolol The metabolism of Timolol can be increased when combined with Adalimumab.
Verapamil Verapamil The metabolism of Verapamil can be increased when combined with Adalimumab.
Atenolol Atenolol The metabolism of Atenolol can be increased when combined with Adalimumab.
Streptozocin Streptozocin The risk or severity of adverse effects can be increased when Adalimumab is combined with Streptozocin.
Buspirone Buspirone The metabolism of Buspirone can be increased when combined with Adalimumab.
Teniposide Injection Teniposide Injection The metabolism of Teniposide can be increased when combined with Adalimumab.
Tramadol Tramadol The metabolism of Tramadol can be increased when combined with Adalimumab.
Lansoprazole Lansoprazole The metabolism of Lansoprazole can be increased when combined with Adalimumab.
Ticlopidine Ticlopidine The metabolism of Ticlopidine can be increased when combined with Adalimumab.
Gemcitabine Injection Gemcitabine Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Gemcitabine.
Indinavir Indinavir The metabolism of Indinavir can be increased when combined with Adalimumab.
Zafirlukast Zafirlukast The metabolism of Zafirlukast can be increased when combined with Adalimumab.
Mirtazapine Mirtazapine The metabolism of Mirtazapine can be increased when combined with Adalimumab.
Donepezil Donepezil The metabolism of Donepezil can be increased when combined with Adalimumab.
Azithromycin Azithromycin The metabolism of Azithromycin can be increased when combined with Adalimumab.
Carvedilol Carvedilol The metabolism of Carvedilol can be increased when combined with Adalimumab.
Palivizumab Injection Palivizumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Palivizumab.
Capecitabine Capecitabine The metabolism of Capecitabine can be increased when combined with Adalimumab.
Efavirenz Efavirenz The metabolism of Efavirenz can be increased when combined with Adalimumab.
Sildenafil Sildenafil The metabolism of Sildenafil can be increased when combined with Adalimumab.
Celecoxib Celecoxib The metabolism of Celecoxib can be increased when combined with Adalimumab.
Tolterodine Tolterodine The metabolism of Tolterodine can be increased when combined with Adalimumab.
Thalidomide Thalidomide The metabolism of Thalidomide can be increased when combined with Adalimumab.
Rabeprazole Rabeprazole The metabolism of Rabeprazole can be increased when combined with Adalimumab.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists